Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening

[1]  J. Little,et al.  Understanding sickle cell carrier status identified through newborn screening: a qualitative study , 2010, European Journal of Human Genetics.

[2]  R. Laessig,et al.  Statewide newborn screening for severe T-cell lymphopenia. , 2009, JAMA.

[3]  C. Castellani,et al.  Inconclusive Cystic Fibrosis neonatal screening results: long‐term psychosocial effects on parents , 2009, Acta paediatrica.

[4]  B. Knoppers,et al.  The expansion of newborn screening: is reproductive benefit an appropriate pursuit? , 2009, Nature Reviews Genetics.

[5]  J. Little,et al.  Consent for Newborn Screening: The Attitudes of Health Care Providers , 2009, Public Health Genomics.

[6]  P. Borry.  Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics , 2009, European Journal of Human Genetics.

[7]  R. Hayeems,et al.  Questioning the consensus: managing carrier status results generated by newborn screening. , 2009, American journal of public health.

[8]  Rachel Grob.  Is my sick child healthy? Is my healthy child sick?: changing parental experiences of cystic fibrosis in the age of expanded newborn screening. , 2008, Social science & medicine.

[9]  A. Davis,et al.  Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues , 2008, Pediatrics.

[10]  R. Pollitt,et al.  Introducing new screens: Why are we all doing different things? , 2007, Journal of Inherited Metabolic Disease.

[11]  S. Waisbren,et al.  A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening , 2006, Journal of Inherited Metabolic Disease.

[12]  Michael S. Watson,et al.  Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary , 2006, Pediatrics.

[13]  D. Alexander,et al.  A Vision of the Future of Newborn Screening , 2006, Pediatrics.

[14]  L. Ross.  Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy , 2006, American journal of medical genetics. Part A.

[15]  Siobhan M. Dolan,et al.  Newborn screening: complexities in universal genetic testing. , 2006, American journal of public health.

[16]  M. Khoury,et al.  From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels , 2006, Pediatrics.

[17]  J. Fryns,et al.  Carrier testing in minors: a systematic review of guidelines and position papers , 2006, European Journal of Human Genetics.

[18]  M. Otlowski.  Essentially yours: the protection of human genetic information in Australia. , 2006, Genewatch : a bulletin of the Committee for Responsible Genetics.

[19]  A. Davis,et al.  Changing perspectives on the benefits of newborn screening. , 2006, Mental retardation and developmental disabilities research reviews.

[20]  S. Warren,et al.  Newborn screening for developmental disabilities: reframing presumptive benefit. , 2005, American journal of public health.

[21]  Karen Golden-Biddle,et al.  Towards systematic reviews that inform health care management and policy-making , 2005, Journal of health services research & policy.

[22]  M. Rosenfeld,et al.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[23]  L. Ross,et al.  Incorporating newborn screening into prenatal care. , 2004, American journal of obstetrics and gynecology.

[24]  R. Trent.  Essentially Yours: The Protection of Human Genetic Information in Australia--the impact on clinical practice and the 'new genetics'. , 2003, The University of New South Wales law journal.

[25]  I. Kohane,et al.  Newborn screening program practices in the United States: notification, research, and consent. , 2002, Pediatrics.

[26]  M. Parker,et al.  Revealing false paternity: some ethical considerations , 2001, The Lancet.

[27]  M. Sandelowski.  Focus on Research Methods Whatever Happened to Qualitative Description? , 2022 .

[28]  T. Takala,et al.  Genetic ignorance, moral obligations and social duties. , 2000, The Journal of medicine and philosophy.

[29]  Anselm L. Strauss,et al.  Basics of qualitative research : techniques and procedures for developing grounded theory , 1998 .

[30]  M. Natowicz,et al.  Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States. , 1997, American journal of public health.

[31]  C. Dezateux,et al.  Fortnightly Review: Neonatal screening for sickle cell disorders: what about the carrier infants? , 1996, BMJ.

[32]  Lori B. Andrews,et al.  Assessing Genetic Risks: Implications for Health and Social Policy , 1994 .

[33]  A. Clarke,et al.  Experience with screening newborns for Duchenne muscular dystrophy in Wales. , 1993, BMJ.

[34]  T. Marteau,et al.  Effects of genetic screening on perceptions of health: a pilot study. , 1992, Journal of medical genetics.

[35]  A. Lundin,et al.  Screening for duchenne muscular dystrophy: An improved screening test for creatine kinase and its application in an infant screening program , 1986, Muscle & nerve.

[36]  H. Ten Have,et al.  Genetic Counseling , 2019, Dictionary of Global Bioethics.

[37]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .